In Vitro Effect of Dovitinib (TKI258), a Multi-Target Angiokinase Inhibitor on Aggressive Meningioma Cells-Reference-Cited by-同舟云学术

In Vitro Effect of Dovitinib (TKI258), a Multi-Target Angiokinase Inhibitor on Aggressive Meningioma Cells

Published:2020-06-08 Issue:6 Volume:38 Page:349-355
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Das Arabinda¹,Martinez Santos Jaime L.¹,Alshareef Mohammed¹,Porto Guilherme Bastos Ferreira¹,Infinger Libby Kosnik¹,Vandergrift William A.¹,Lindhorst Scott M.¹,Varma Abhay K.¹,Patel Sunil J.¹,Cachia David¹

Affiliation:

1. Department of Neurosurgery and MUSC Brain & Spine Tumor Program, Medical University of South Carolina, Charleston, South Carolina, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07357907.2020.1773844

Reference21 articles.

1. Diagnostic and molecular pathology of meningiomas

2. Molecular Targets and Treatment of Meningioma

3. A review of malignant meningiomas: diagnosis, characteristics, and treatment

4. WHO Grade III Anaplastic Meningioma Metastasizing to the Parotid Gland and the Lungs: Case Report and Review of the Literature

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benzimidazole‐oxindole hybrids: A novel class of selective dual CDK2 and GSK‐3β inhibitors of potent anticancer activity;Archiv der Pharmazie;2024-07-23

2. Benzimidazole scaffold as a potent anticancer agent with different mechanisms of action (2016–2023);Molecular Diversity;2024-07-20

3. Modeling Meningiomas;Neurosurgery Clinics of North America;2023-07

4. Design, synthesis and biological evaluation of novel indolin-2-one derivatives as potent second-generation TRKs inhibitors;European Journal of Medicinal Chemistry;2023-05

5. New 1,3,4‐oxadiazole‐chalcone/benzimidazole hybrids as potent antiproliferative agents;Archiv der Pharmazie;2022-11-09